As a modified fragment of human growth hormone (hGH), this peptide focuses on fat metabolism without the typical side effects associated with full hGH therapy, such as insulin resistance or increased IGF-1 levels
Certain groupssuch as older adults, vegetarians, individuals with gastrointestinal disorders, and those taking specific medications (e.g., metformin or proton pump inhibitors)may develop a B12 deficiency
This dual mechanism distinguishes it from semaglutide with B12 , which targets only GLP-1 receptors
However, it may also be administered slowly by intravenous or subcutaneous injection
Additionally, it assists in metabolizing homocysteine, a compound linked with cardiovascular risks when present in excess